HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Matthew Biancalana Selected Research
Matthew Biancalana Research Topics
Disease
4
Neoplasms (Cancer)
10/2023 - 01/2018
2
Breast Neoplasms (Breast Cancer)
10/2023 - 01/2023
2
Triple Negative Breast Neoplasms
10/2023 - 01/2023
2
Proteostasis Deficiencies
02/2010 - 01/2009
1
Pathologic Complete Response
01/2023
1
Lymphadenopathy
01/2020
1
Cytopenia
01/2020
1
Dysgammaglobulinemia
01/2020
1
Liver Diseases (Liver Disease)
01/2020
1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
01/2020
1
Idiopathic CD4-Positive T-Lymphocytopenia (T Lymphocytopenia, Idiopathic CD4 Positive)
01/2020
1
Epstein-Barr Virus Infections
01/2020
1
Autoimmune Lymphoproliferative Syndrome
01/2020
1
Pathologic Constriction (Stenosis)
06/2017
1
Disease Progression
01/2014
Drug/Important Bio-Agent (IBA)
2
Biomarkers (Surrogate Marker)
IBA
01/2023 - 01/2020
1
human ERBB2 protein
IBA
10/2023
1
Hormones (Hormone)
IBA
10/2023
1
N-acetyltalosaminuronic acid (NAT)
IBA
10/2023
1
Antibodies
IBA
01/2023
1
RNA (Ribonucleic Acid)
IBA
01/2023
1
Immune Checkpoint Inhibitors
IBA
01/2023
1
Magnesium
IBA
01/2020
1
Glycoproteins (Glycoprotein)
IBA
01/2020
1
NK Cell Lectin-Like Receptor Subfamily K
IBA
01/2020
1
Phenobarbital (Luminal)
FDA Link
06/2017
1
Sirolimus (Rapamycin)
FDA Link
01/2014
1
Amyloid (Amyloid Fibrils)
IBA
02/2010
1
Coloring Agents (Dyes)
IBA
01/2009
1
thioflavin T
IBA
01/2009
Therapy/Procedure
2
Therapeutics
10/2023 - 01/2023
2
Immunotherapy
01/2023 - 01/2018
1
Neoadjuvant Therapy
10/2023
1
Precision Medicine
10/2023